"Designing Growth Strategies is in our DNA"

U.S Secondary Hyperparathyroidism (SHPT) Treatment Market Size, Share & Industry Analysis, By Drug Class (Calcimimetics, Vitamin D Analogues, and Phosphate Binders), By Distribution Channel (Hospital & Retail Pharmacies, Online Channels, and Others), and Region Forecast 2019-2026

The U.S secondary hyperparathyroidism (SHPT) treatment market size was at USD 4.34 billion in 2018 and is projected to reach USD 7.06 billion by 2026, exhibiting a CAGR o... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Nov, 2019 | Report ID: FBI101664 | Status : Published

 

Request Sample PDF

Refresh Button
U.S. Secondary Hyperparathyroidism (SHPT) Treatment Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2015-2017
  • 114
  • Choose License Type
  • 2850
    4850
    6850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X